Medicare drug price negotiation affects which dermatologic therapies stay accessible — and advocates need to be at the table when those decisions are made.
This toolkit gives DCAN members and partners ready-to-use materials: talking points, a template comment letter, and background on how negotiated prices flow through to formulary design and patient cost-sharing.
This is sample copy — upload the toolkit PDF in the Media library and attach it to this resource from the site admin.
